ACRV
Acrivon Therapeutics, Inc.
2.10$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -0.22 | -1.08 | -1.37 | -1.93 | -1.71 | -1.65 | |
| 0.00 | 0.00 | 0.02 | 0.02 | 0.03 | 0.02 | |
| 0.00 | 0.04 | 0.10 | 0.53 | 0.37 | 0.38 | |
| 0.17 | 0.15 | 0.10 | – | – | – | |
| 0.02 | 0.03 | -0.07 | 0.37 | 0.06 | -0.06 | |
| 0.00 | 0.02 | 0.10 | 0.06 | 0.07 | 0.04 | |
| 0.00 | -0.02 | -6.46 | 2.30 | -1.35 | 1.72 | |
| – | – | 4.64 | – | – | – | |
| 0.00 | 0.00 | – | – | – | – | |
| 0.22 | 8.69 | 4.64 | -0.07 | 3.16 | -0.02 | |
| 0.01 | 7.59 | -3.20 | 0.30 | 0.09 | 0.04 | |
| -0.22 | -1.10 | -1.47 | -1.99 | -1.79 | -1.70 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.